| 供货周期： | 一周 |
| 品牌： | 爱必信 |
| 规格： | 99% |
| 货号： | abs817968 |
| CAS号： | 405168-58-3 |
| 公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!
抑制剂描述： 产品名称：CHIR-124 产品别名：见爱必信官网 英文别名：CHIR-124 靶点：Chk CAS：405168-58-3 纯度：99% 外观：见爱必信官网 保存方法：﹣20 ℃冷藏长期储存。冰袋运输 描述： CHIR-124是高活性的Chk1抑制剂，IC50为0.3 nM，比对Chk2，CDK2/4和Cdc2的抑制性高2000倍，500倍和5000倍 溶解性：DMSO:7 mg/mL 体外研究： CHIR-124 is a quinolone-based small molecule that is structurally unrelated to other known inhibitors of Chk1. CHIR-124 interacts synergistically with topoisomerase poisons (e.g., Camptothecin or SN-38) in causing growth inhibition in a variety of cancer cell lines, including breast carcinoma (MDA-MB-231 and MDA-MB-435) and colon carcinoma (SW-620 and Colo205), all of which contains the mutant p53 gene. CHIR-124 abrogates the SN-38-induced S and G2-M checkpoints and potentiates apoptosis in MDA-MD-435 breast cancer cells. The abrogation of the G2-Mcheckpoint and induction of apoptosis by CHIR-124 are enhanced by the loss of p53. CHIR-124 also potently targets other kinases such as PDGFR and Flt3 with IC50 of 6.6 nM and 5.8 nM, respectively. 体内研究：CHIR-124 potentiates the growth inhibitory effects of Irinotecan by abrogating the G2-M checkpoint and increasing tumor apoptosis in an orthotopic breast cancer xenograft model.
产品信息订购：
|
相关产品
工商信息
信息已认证
联系方式
详细地址
关注
拨打电话
留言咨询
